C4 Therapeutics (CCCC) Other Non-Current Assets (2019 - 2026)

C4 Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (changed 0.0% YoY), while the FY2025 annual figure was $3.7 million, up 6.97% from the prior year.
• Other Non-Current Assets was $3.4 million for Q1 2026 at C4 Therapeutics, down from $3.7 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.7 million in Q4 2025 to a low of $211000.0 in Q3 2025.
• Historically, Other Non-Current Assets has averaged $3.2 million across 5 years, with a median of $3.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets jumped 156.97% in 2022, then tumbled 93.87% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $3.3 million in 2022, then advanced by 5.0% to $3.4 million in 2023, then changed by 0.0% to $3.4 million in 2024, then climbed by 6.97% to $3.7 million in 2025, then retreated by 6.52% to $3.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $3.4 million (Q1 2026), $3.7 million (Q4 2025), and $211000.0 (Q3 2025), per Business Quant data.